

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.59151758 |
| 2 | muscle filament sliding (GO:0030049) | 6.59151758 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 5.64763161 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.64688686 |
| 5 | sarcomere organization (GO:0045214) | 5.40619064 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.13235497 |
| 7 | myofibril assembly (GO:0030239) | 5.01241501 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.97848869 |
| 9 | inositol phosphate catabolic process (GO:0071545) | 4.71677941 |
| 10 | inositol phosphate dephosphorylation (GO:0046855) | 4.62207060 |
| 11 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.62207060 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.55624338 |
| 13 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.54164218 |
| 14 | actin filament-based movement (GO:0030048) | 4.38864247 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.26898545 |
| 16 | protein K6-linked ubiquitination (GO:0085020) | 4.25854204 |
| 17 | skeletal muscle contraction (GO:0003009) | 4.25486618 |
| 18 | mitotic chromosome condensation (GO:0007076) | 4.24016921 |
| 19 | IMP metabolic process (GO:0046040) | 4.17330585 |
| 20 | regulation of hexokinase activity (GO:1903299) | 4.10801577 |
| 21 | regulation of glucokinase activity (GO:0033131) | 4.10801577 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.08159216 |
| 23 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.02973986 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 4.01233468 |
| 25 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.93793494 |
| 26 | cardiac muscle cell development (GO:0055013) | 3.92843538 |
| 27 | IMP biosynthetic process (GO:0006188) | 3.91410925 |
| 28 | striated muscle contraction (GO:0006941) | 3.89265097 |
| 29 | plasma membrane repair (GO:0001778) | 3.84632664 |
| 30 | glycogen catabolic process (GO:0005980) | 3.78730599 |
| 31 | regulation of meiosis I (GO:0060631) | 3.78242102 |
| 32 | synapsis (GO:0007129) | 3.77684011 |
| 33 | mitotic sister chromatid cohesion (GO:0007064) | 3.76224767 |
| 34 | protein targeting to Golgi (GO:0000042) | 3.74729209 |
| 35 | regulation of coenzyme metabolic process (GO:0051196) | 3.72136938 |
| 36 | regulation of cofactor metabolic process (GO:0051193) | 3.72136938 |
| 37 | cardiac cell development (GO:0055006) | 3.71389541 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 3.70190540 |
| 39 | skeletal muscle adaptation (GO:0043501) | 3.68227919 |
| 40 | cardiac muscle contraction (GO:0060048) | 3.66017801 |
| 41 | establishment of protein localization to Golgi (GO:0072600) | 3.64674091 |
| 42 | glucan biosynthetic process (GO:0009250) | 3.58353278 |
| 43 | glycogen biosynthetic process (GO:0005978) | 3.58353278 |
| 44 | mitotic metaphase plate congression (GO:0007080) | 3.56956183 |
| 45 | positive regulation of meiosis (GO:0045836) | 3.56437446 |
| 46 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.54421078 |
| 47 | protein localization to kinetochore (GO:0034501) | 3.54395480 |
| 48 | nuclear pore complex assembly (GO:0051292) | 3.52781833 |
| 49 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.49400042 |
| 50 | tricarboxylic acid cycle (GO:0006099) | 3.48060613 |
| 51 | cardiac muscle hypertrophy (GO:0003300) | 3.47301816 |
| 52 | actomyosin structure organization (GO:0031032) | 3.47271330 |
| 53 | meiotic chromosome segregation (GO:0045132) | 3.44910994 |
| 54 | regulation of sarcomere organization (GO:0060297) | 3.42143889 |
| 55 | heart process (GO:0003015) | 3.41526172 |
| 56 | heart contraction (GO:0060047) | 3.41526172 |
| 57 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41153947 |
| 58 | glucan catabolic process (GO:0009251) | 3.40639683 |
| 59 | regulation of energy homeostasis (GO:2000505) | 3.39218580 |
| 60 | response to muscle activity (GO:0014850) | 3.37447787 |
| 61 | striated muscle hypertrophy (GO:0014897) | 3.34679874 |
| 62 | nuclear pore organization (GO:0006999) | 3.34079328 |
| 63 | polyketide metabolic process (GO:0030638) | 3.33885090 |
| 64 | doxorubicin metabolic process (GO:0044598) | 3.33885090 |
| 65 | daunorubicin metabolic process (GO:0044597) | 3.33885090 |
| 66 | polyol catabolic process (GO:0046174) | 3.33433492 |
| 67 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.31987334 |
| 68 | response to inactivity (GO:0014854) | 3.30747113 |
| 69 | carnitine shuttle (GO:0006853) | 3.30504953 |
| 70 | positive regulation of meiotic cell cycle (GO:0051446) | 3.26896001 |
| 71 | piRNA metabolic process (GO:0034587) | 3.24650661 |
| 72 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.22200444 |
| 73 | metaphase plate congression (GO:0051310) | 3.20581425 |
| 74 | regulation of spindle organization (GO:0090224) | 3.13771230 |
| 75 | cellular polysaccharide catabolic process (GO:0044247) | 3.11599408 |
| 76 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.07229934 |
| 77 | protein localization to chromosome, centromeric region (GO:0071459) | 3.05144502 |
| 78 | negative regulation of meiosis (GO:0045835) | 3.04406054 |
| 79 | regulation of sulfur metabolic process (GO:0042762) | 3.03045428 |
| 80 | skeletal muscle tissue regeneration (GO:0043403) | 3.02360141 |
| 81 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.01700874 |
| 82 | lactate metabolic process (GO:0006089) | 2.98525542 |
| 83 | cytidine deamination (GO:0009972) | 2.96736584 |
| 84 | cytidine metabolic process (GO:0046087) | 2.96736584 |
| 85 | cytidine catabolic process (GO:0006216) | 2.96736584 |
| 86 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.96611160 |
| 87 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.95668697 |
| 88 | phospholipid dephosphorylation (GO:0046839) | 2.95649355 |
| 89 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.94531285 |
| 90 | regulation of DNA endoreduplication (GO:0032875) | 2.94162933 |
| 91 | muscle hypertrophy (GO:0014896) | 2.93856282 |
| 92 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.93653081 |
| 93 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.91748563 |
| 94 | Golgi to endosome transport (GO:0006895) | 2.91313746 |
| 95 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.91025460 |
| 96 | negative regulation of histone methylation (GO:0031061) | 2.88041418 |
| 97 | positive regulation of glycolytic process (GO:0045821) | 2.87910201 |
| 98 | striated muscle adaptation (GO:0014888) | 2.87271416 |
| 99 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.84661659 |
| 100 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.83169970 |
| 101 | establishment of chromosome localization (GO:0051303) | 2.81651275 |
| 102 | myotube cell development (GO:0014904) | 2.81368116 |
| 103 | pore complex assembly (GO:0046931) | 2.79758808 |
| 104 | skeletal muscle fiber development (GO:0048741) | 2.79394044 |
| 105 | skeletal muscle tissue development (GO:0007519) | 2.78415885 |
| 106 | mitotic nuclear envelope disassembly (GO:0007077) | 2.78354140 |
| 107 | regulation of actin filament-based movement (GO:1903115) | 2.78089961 |
| 108 | macroautophagy (GO:0016236) | 2.77750065 |
| 109 | polysaccharide catabolic process (GO:0000272) | 2.76987238 |
| 110 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.76466035 |
| 111 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.76466035 |
| 112 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.76466035 |
| 113 | muscle cell cellular homeostasis (GO:0046716) | 2.74182829 |
| 114 | regulation of protein glycosylation (GO:0060049) | 2.74174071 |
| 115 | N-terminal protein amino acid acetylation (GO:0006474) | 2.73570558 |
| 116 | spindle checkpoint (GO:0031577) | 2.72503468 |
| 117 | regulation of Rac protein signal transduction (GO:0035020) | 2.72027384 |
| 118 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.70721943 |
| 119 | kinetochore organization (GO:0051383) | 2.70347119 |
| 120 | paraxial mesoderm development (GO:0048339) | 2.69890545 |
| 121 | muscle system process (GO:0003012) | 2.69518851 |
| 122 | striated muscle cell development (GO:0055002) | 2.69236339 |
| 123 | muscle fiber development (GO:0048747) | 2.69163278 |
| 124 | COPII vesicle coating (GO:0048208) | 2.68543033 |
| 125 | muscle tissue morphogenesis (GO:0060415) | 2.67962168 |
| 126 | muscle contraction (GO:0006936) | 2.67447189 |
| 127 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.66609394 |
| 128 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.66601856 |
| 129 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.65621590 |
| 130 | DNA replication-independent nucleosome organization (GO:0034724) | 2.65621590 |
| 131 | fatty acid transmembrane transport (GO:1902001) | 2.65008790 |
| 132 | endoplasmic reticulum organization (GO:0007029) | 2.64121844 |
| 133 | regulation of mitotic spindle organization (GO:0060236) | 2.62494371 |
| 134 | nuclear envelope disassembly (GO:0051081) | 2.62265150 |
| 135 | membrane disassembly (GO:0030397) | 2.62265150 |
| 136 | magnesium ion transport (GO:0015693) | 2.61851871 |
| 137 | regulation of calcium ion import (GO:0090279) | 2.61550820 |
| 138 | fibroblast migration (GO:0010761) | 2.60969766 |
| 139 | DNA demethylation (GO:0080111) | 2.60644032 |
| 140 | adult heart development (GO:0007512) | 2.60360305 |
| 141 | protein K11-linked deubiquitination (GO:0035871) | 2.59820208 |
| 142 | protein localization to chromosome (GO:0034502) | 2.59385108 |
| 143 | sister chromatid cohesion (GO:0007062) | 2.58781308 |
| 144 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.58287319 |
| 145 | muscle hypertrophy in response to stress (GO:0003299) | 2.58287319 |
| 146 | cardiac muscle adaptation (GO:0014887) | 2.58287319 |
| 147 | DNA replication checkpoint (GO:0000076) | 2.57888576 |
| 148 | interkinetic nuclear migration (GO:0022027) | 2.55890657 |
| 149 | glycogen metabolic process (GO:0005977) | 2.55815259 |
| 150 | spindle assembly checkpoint (GO:0071173) | 2.55570309 |
| 151 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.55557137 |
| 152 | resolution of meiotic recombination intermediates (GO:0000712) | 2.55519345 |
| 153 | CENP-A containing nucleosome assembly (GO:0034080) | 2.55512045 |
| 154 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.53301429 |
| 155 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.53270956 |
| 156 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.53061709 |
| 157 | lipid particle organization (GO:0034389) | 2.51393547 |
| 158 | succinate metabolic process (GO:0006105) | 2.50716723 |
| 159 | positive regulation of gluconeogenesis (GO:0045722) | 2.48502924 |
| 160 | muscle organ morphogenesis (GO:0048644) | 2.46194767 |
| 161 | cellular glucan metabolic process (GO:0006073) | 2.45801724 |
| 162 | glucan metabolic process (GO:0044042) | 2.45801724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.67723358 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.33953064 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.01373746 |
| 4 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.34408254 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21072822 |
| 6 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.10129931 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07571584 |
| 8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.85176087 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.78898804 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.77725420 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.72738861 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.65952919 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.56386967 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.37277038 |
| 15 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.33765067 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.29744428 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29180612 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27289927 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25657887 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19470147 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.19143461 |
| 22 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.18592090 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08714001 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.07648782 |
| 25 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.05746763 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05717751 |
| 27 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.03493728 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.01819213 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99459934 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.93585848 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92074364 |
| 32 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.91335997 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.88476572 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.86997187 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86062186 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.82562044 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81683739 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.79130509 |
| 39 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75195951 |
| 40 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.74195516 |
| 41 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.73945575 |
| 42 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.73874732 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.73357010 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72476468 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69463750 |
| 46 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.68922038 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.68503170 |
| 48 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.67922096 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.64090094 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.62423894 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62396339 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.60684829 |
| 53 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.59601405 |
| 54 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59169482 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.58637884 |
| 56 | VDR_22108803_ChIP-Seq_LS180_Human | 1.58628878 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57828061 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57658218 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56743647 |
| 60 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.55700356 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.54900638 |
| 62 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.54626511 |
| 63 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.54168313 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53895429 |
| 65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.53370867 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52019656 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51720425 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50640401 |
| 69 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.49240038 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49150549 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49093443 |
| 72 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49093425 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48300431 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47895059 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46874625 |
| 76 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.46794997 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.45503390 |
| 78 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45292416 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44068166 |
| 80 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.43977148 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.43595071 |
| 82 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41594957 |
| 83 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40765790 |
| 84 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.39312475 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.36728750 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36600601 |
| 87 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.36344236 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35149772 |
| 89 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33894091 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33116062 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32326150 |
| 92 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.31132249 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30055019 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29244643 |
| 95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27935113 |
| 96 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.27315742 |
| 97 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.26857617 |
| 98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.26745580 |
| 99 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26656787 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25246154 |
| 101 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25119501 |
| 102 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24990726 |
| 103 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24570573 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.22668065 |
| 105 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.22485783 |
| 106 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.22053601 |
| 107 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21355168 |
| 108 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20616443 |
| 109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19882173 |
| 110 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.19266609 |
| 111 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19185561 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18960792 |
| 113 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18307280 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18307280 |
| 115 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17545803 |
| 116 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17052083 |
| 117 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17052083 |
| 118 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.16637525 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16135041 |
| 120 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15713921 |
| 121 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14489689 |
| 122 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.14196070 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13557977 |
| 124 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13199299 |
| 125 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12989412 |
| 126 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12658450 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11448316 |
| 128 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10574009 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10574009 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.10223313 |
| 131 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08420632 |
| 132 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08202393 |
| 133 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.07615402 |
| 134 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.07472183 |
| 135 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.07265923 |
| 136 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06249432 |
| 137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06053746 |
| 138 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.04942086 |
| 139 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04808413 |
| 140 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03581394 |
| 141 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02933350 |
| 142 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02805114 |
| 143 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01629285 |
| 144 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01192833 |
| 145 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01192833 |
| 146 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.00890872 |
| 147 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99646495 |
| 148 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.99377253 |
| 149 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98730249 |
| 150 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97990062 |
| 151 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97408476 |
| 152 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97354090 |
| 153 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96399173 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95620692 |
| 155 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94224090 |
| 156 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91519762 |
| 157 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91341963 |
| 158 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89048786 |
| 159 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.87711572 |
| 160 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87608225 |
| 161 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87373472 |
| 162 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86237009 |
| 163 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86136006 |
| 164 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.84844920 |
| 165 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.84576443 |
| 166 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83101494 |
| 167 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80506951 |
| 168 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80306287 |
| 169 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.79502288 |
| 170 | FUS_26573619_Chip-Seq_HEK293_Human | 0.78125697 |
| 171 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.77105172 |
| 172 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.74191783 |
| 173 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.72551876 |
| 174 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.71823192 |
| 175 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.71331117 |
| 176 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.70882343 |
| 177 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70168738 |
| 178 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.69916314 |
| 179 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.69700293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.23387272 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.10573123 |
| 3 | MP0000751_myopathy | 3.98398463 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.85227859 |
| 5 | MP0000749_muscle_degeneration | 3.78541637 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.50006343 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.40204544 |
| 8 | MP0004215_abnormal_myocardial_fiber | 2.94839423 |
| 9 | MP0000013_abnormal_adipose_tissue | 2.85164338 |
| 10 | MP0002106_abnormal_muscle_physiology | 2.81009504 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 2.79836946 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.61397784 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.38530928 |
| 14 | MP0005330_cardiomyopathy | 2.38388083 |
| 15 | MP0008057_abnormal_DNA_replication | 2.38345479 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.37389708 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.31185834 |
| 18 | MP0003221_abnormal_cardiomyocyte_apopto | 2.26417138 |
| 19 | MP0002269_muscular_atrophy | 2.15907814 |
| 20 | MP0005369_muscle_phenotype | 2.15871398 |
| 21 | MP0000759_abnormal_skeletal_muscle | 2.13924039 |
| 22 | MP0000747_muscle_weakness | 2.08309990 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.05184166 |
| 24 | MP0003077_abnormal_cell_cycle | 2.04746363 |
| 25 | MP0008775_abnormal_heart_ventricle | 1.98212525 |
| 26 | MP0002972_abnormal_cardiac_muscle | 1.97418213 |
| 27 | MP0004130_abnormal_muscle_cell | 1.96187577 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.94665431 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.90771438 |
| 30 | MP0002009_preneoplasia | 1.83167835 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.82731987 |
| 32 | MP0004233_abnormal_muscle_weight | 1.79495445 |
| 33 | MP0004484_altered_response_of | 1.78981652 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.75265963 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.71614861 |
| 36 | MP0003828_pulmonary_edema | 1.70130871 |
| 37 | MP0008007_abnormal_cellular_replicative | 1.67452358 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.67222501 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.67222501 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.61666033 |
| 41 | MP0000733_abnormal_muscle_development | 1.59936502 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.57183515 |
| 43 | MP0004510_myositis | 1.49666554 |
| 44 | MP0008058_abnormal_DNA_repair | 1.49635811 |
| 45 | MP0000427_abnormal_hair_cycle | 1.49100084 |
| 46 | MP0002396_abnormal_hematopoietic_system | 1.39075253 |
| 47 | MP0004957_abnormal_blastocyst_morpholog | 1.38413899 |
| 48 | MP0006138_congestive_heart_failure | 1.37428168 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.34678481 |
| 50 | MP0002163_abnormal_gland_morphology | 1.33729534 |
| 51 | MP0003045_fibrosis | 1.32632470 |
| 52 | MP0003984_embryonic_growth_retardation | 1.31879799 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.31269318 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.30764020 |
| 55 | MP0001661_extended_life_span | 1.30081254 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.29978526 |
| 57 | MP0004270_analgesia | 1.29149792 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.29035045 |
| 59 | MP0002088_abnormal_embryonic_growth/wei | 1.27916815 |
| 60 | MP0000350_abnormal_cell_proliferation | 1.27680998 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.26108039 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.24611496 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.22674636 |
| 64 | MP0005380_embryogenesis_phenotype | 1.22674636 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.16899219 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.14717984 |
| 67 | MP0002693_abnormal_pancreas_physiology | 1.13330537 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.12792646 |
| 69 | MP0004134_abnormal_chest_morphology | 1.12467259 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.11528016 |
| 71 | MP0000266_abnormal_heart_morphology | 1.10288952 |
| 72 | MP0005451_abnormal_body_composition | 1.08892677 |
| 73 | MP0001299_abnormal_eye_distance/ | 1.08527000 |
| 74 | MP0001730_embryonic_growth_arrest | 1.08067856 |
| 75 | MP0003786_premature_aging | 1.07749030 |
| 76 | MP0003123_paternal_imprinting | 1.03169547 |
| 77 | MP0002971_abnormal_brown_adipose | 1.02148610 |
| 78 | MP0001697_abnormal_embryo_size | 0.96480313 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.96047580 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.91779042 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.91669563 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.91147170 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.90967875 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.90676640 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 0.89612548 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.88871622 |
| 87 | MP0003787_abnormal_imprinting | 0.87831782 |
| 88 | MP0004197_abnormal_fetal_growth/weight/ | 0.87806528 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.87585877 |
| 90 | MP0003121_genomic_imprinting | 0.86511798 |
| 91 | MP0010307_abnormal_tumor_latency | 0.86507172 |
| 92 | MP0004085_abnormal_heartbeat | 0.86030082 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.85969427 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.84987306 |
| 95 | MP0009697_abnormal_copulation | 0.84981992 |
| 96 | MP0002177_abnormal_outer_ear | 0.84735286 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.82376378 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.80752979 |
| 99 | MP0002166_altered_tumor_susceptibility | 0.79169581 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.79124386 |
| 101 | MP0005266_abnormal_metabolism | 0.78386702 |
| 102 | MP0002168_other_aberrant_phenotype | 0.78131205 |
| 103 | MP0002086_abnormal_extraembryonic_tissu | 0.77234992 |
| 104 | MP0005253_abnormal_eye_physiology | 0.76772491 |
| 105 | MP0002085_abnormal_embryonic_tissue | 0.74764730 |
| 106 | MP0009672_abnormal_birth_weight | 0.74220967 |
| 107 | MP0005187_abnormal_penis_morphology | 0.74007267 |
| 108 | MP0001984_abnormal_olfaction | 0.73372265 |
| 109 | MP0002080_prenatal_lethality | 0.72317288 |
| 110 | MP0003718_maternal_effect | 0.71718485 |
| 111 | MP0002084_abnormal_developmental_patter | 0.71667739 |
| 112 | MP0000343_altered_response_to | 0.71366118 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.68392626 |
| 114 | MP0003195_calcinosis | 0.68170455 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.67243037 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.66542745 |
| 117 | MP0002108_abnormal_muscle_morphology | 0.66530625 |
| 118 | MP0000313_abnormal_cell_death | 0.65087012 |
| 119 | MP0004147_increased_porphyrin_level | 0.64694323 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.62599328 |
| 121 | MP0002210_abnormal_sex_determination | 0.62059988 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.61691323 |
| 123 | MP0001243_abnormal_dermal_layer | 0.61533799 |
| 124 | MP0009046_muscle_twitch | 0.60474201 |
| 125 | MP0010386_abnormal_urinary_bladder | 0.60199468 |
| 126 | MP0001119_abnormal_female_reproductive | 0.60056894 |
| 127 | MP0000358_abnormal_cell_content/ | 0.59829580 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.59725707 |
| 129 | MP0002128_abnormal_blood_circulation | 0.58900143 |
| 130 | MP0006054_spinal_hemorrhage | 0.58697607 |
| 131 | MP0005395_other_phenotype | 0.57590868 |
| 132 | MP0001529_abnormal_vocalization | 0.56470837 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.55938263 |
| 134 | MP0001879_abnormal_lymphatic_vessel | 0.55333117 |
| 135 | MP0003941_abnormal_skin_development | 0.55257009 |
| 136 | MP0004924_abnormal_behavior | 0.54792558 |
| 137 | MP0005386_behavior/neurological_phenoty | 0.54792558 |
| 138 | MP0002019_abnormal_tumor_incidence | 0.54543089 |
| 139 | MP0002398_abnormal_bone_marrow | 0.53296044 |
| 140 | MP0008961_abnormal_basal_metabolism | 0.53063484 |
| 141 | MP0005375_adipose_tissue_phenotype | 0.51320045 |
| 142 | MP0000569_abnormal_digit_pigmentation | 0.51068880 |
| 143 | MP0001835_abnormal_antigen_presentation | 0.49967388 |
| 144 | MP0003935_abnormal_craniofacial_develop | 0.49230793 |
| 145 | MP0000703_abnormal_thymus_morphology | 0.47681665 |
| 146 | MP0001784_abnormal_fluid_regulation | 0.47343626 |
| 147 | MP0003705_abnormal_hypodermis_morpholog | 0.47270744 |
| 148 | MP0001800_abnormal_humoral_immune | 0.47110358 |
| 149 | MP0000689_abnormal_spleen_morphology | 0.47097039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.98627693 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.79586178 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.76681811 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.50388283 |
| 5 | Nemaline bodies (HP:0003798) | 6.46775226 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.43544102 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.32902021 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.81533187 |
| 9 | Subaortic stenosis (HP:0001682) | 4.66392800 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.66392800 |
| 11 | Muscle fiber splitting (HP:0003555) | 4.65024440 |
| 12 | Sudden death (HP:0001699) | 4.52486339 |
| 13 | Abnormality of the calf musculature (HP:0001430) | 4.00962697 |
| 14 | Myoglobinuria (HP:0002913) | 3.89762850 |
| 15 | Ventricular tachycardia (HP:0004756) | 3.89265820 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 3.85439232 |
| 17 | Distal arthrogryposis (HP:0005684) | 3.78636632 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.72586884 |
| 19 | Increased connective tissue (HP:0009025) | 3.65167343 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.60701038 |
| 21 | Difficulty running (HP:0009046) | 3.60355142 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 3.41542205 |
| 23 | Hypoplastic ischia (HP:0003175) | 3.40849553 |
| 24 | Myopathic facies (HP:0002058) | 3.39301958 |
| 25 | Rimmed vacuoles (HP:0003805) | 3.36453373 |
| 26 | Atrial fibrillation (HP:0005110) | 3.30578673 |
| 27 | Areflexia of lower limbs (HP:0002522) | 3.08675557 |
| 28 | Lipoatrophy (HP:0100578) | 3.05270909 |
| 29 | Primary atrial arrhythmia (HP:0001692) | 3.04892613 |
| 30 | Supraventricular tachycardia (HP:0004755) | 2.97068339 |
| 31 | Muscle stiffness (HP:0003552) | 2.91499794 |
| 32 | Calcaneovalgus deformity (HP:0001848) | 2.90891677 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 2.87638352 |
| 34 | Myotonia (HP:0002486) | 2.85800392 |
| 35 | Abnormality of the ischium (HP:0003174) | 2.85138111 |
| 36 | Neck muscle weakness (HP:0000467) | 2.83803453 |
| 37 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.82564931 |
| 38 | Pelvic girdle muscle weakness (HP:0003749) | 2.80127380 |
| 39 | Round ear (HP:0100830) | 2.77469095 |
| 40 | Shoulder girdle muscle weakness (HP:0003547) | 2.75469211 |
| 41 | Deformed tarsal bones (HP:0008119) | 2.64512832 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 2.58767769 |
| 43 | Slender build (HP:0001533) | 2.57949712 |
| 44 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.57262027 |
| 45 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.57262027 |
| 46 | Hyperglycemia (HP:0003074) | 2.51353454 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.45334065 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.45020191 |
| 49 | Absent phalangeal crease (HP:0006109) | 2.43981118 |
| 50 | Dilated cardiomyopathy (HP:0001644) | 2.40658613 |
| 51 | Abnormality of alanine metabolism (HP:0010916) | 2.37126057 |
| 52 | Hyperalaninemia (HP:0003348) | 2.37126057 |
| 53 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37126057 |
| 54 | Pheochromocytoma (HP:0002666) | 2.35919934 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.29056210 |
| 56 | Chromsome breakage (HP:0040012) | 2.26856534 |
| 57 | Malignant hyperthermia (HP:0002047) | 2.26671752 |
| 58 | Hip contracture (HP:0003273) | 2.17311212 |
| 59 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.15835661 |
| 60 | Delayed gross motor development (HP:0002194) | 2.14352449 |
| 61 | Bundle branch block (HP:0011710) | 2.13826919 |
| 62 | Abnormality of lateral ventricle (HP:0030047) | 2.13428946 |
| 63 | Neuroendocrine neoplasm (HP:0100634) | 2.11257615 |
| 64 | Papillary thyroid carcinoma (HP:0002895) | 2.10140491 |
| 65 | Facial diplegia (HP:0001349) | 2.08713161 |
| 66 | Abnormality of the calcaneus (HP:0008364) | 2.08435597 |
| 67 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.03049723 |
| 68 | Proximal amyotrophy (HP:0007126) | 2.00816265 |
| 69 | Gowers sign (HP:0003391) | 2.00540113 |
| 70 | Fetal akinesia sequence (HP:0001989) | 1.99362044 |
| 71 | Frequent falls (HP:0002359) | 1.98986950 |
| 72 | Ketoacidosis (HP:0001993) | 1.98964183 |
| 73 | Hyperkalemia (HP:0002153) | 1.98082691 |
| 74 | Ventricular arrhythmia (HP:0004308) | 1.93707898 |
| 75 | Unilateral renal agenesis (HP:0000122) | 1.93132309 |
| 76 | EMG: neuropathic changes (HP:0003445) | 1.92394053 |
| 77 | Spinal rigidity (HP:0003306) | 1.92095369 |
| 78 | Abnormal finger flexion creases (HP:0006143) | 1.91757262 |
| 79 | Limb-girdle muscle weakness (HP:0003325) | 1.91536980 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89999384 |
| 81 | Biliary tract neoplasm (HP:0100574) | 1.86659120 |
| 82 | Right ventricular cardiomyopathy (HP:0011663) | 1.86591927 |
| 83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86561047 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85326963 |
| 85 | Scapular winging (HP:0003691) | 1.83887860 |
| 86 | Left ventricular hypertrophy (HP:0001712) | 1.82415290 |
| 87 | Abnormality of the pubic bones (HP:0003172) | 1.82078407 |
| 88 | Irregular epiphyses (HP:0010582) | 1.81632093 |
| 89 | Muscular dystrophy (HP:0003560) | 1.81291336 |
| 90 | Weak cry (HP:0001612) | 1.79099752 |
| 91 | Generalized muscle weakness (HP:0003324) | 1.77607950 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.76799702 |
| 93 | Limb-girdle muscle atrophy (HP:0003797) | 1.76671706 |
| 94 | Wrist flexion contracture (HP:0001239) | 1.74781358 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73897907 |
| 96 | Syncope (HP:0001279) | 1.73556566 |
| 97 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.73244687 |
| 98 | Cutaneous melanoma (HP:0012056) | 1.72806586 |
| 99 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72670880 |
| 100 | Hypoplasia of the fovea (HP:0007750) | 1.72670880 |
| 101 | Thyroid carcinoma (HP:0002890) | 1.71966321 |
| 102 | Heart block (HP:0012722) | 1.70266906 |
| 103 | Palpitations (HP:0001962) | 1.69980940 |
| 104 | Abnormality of the fingertips (HP:0001211) | 1.69309043 |
| 105 | Small epiphyses (HP:0010585) | 1.69218719 |
| 106 | Limited hip movement (HP:0008800) | 1.68715892 |
| 107 | Hypoglycemic coma (HP:0001325) | 1.66096908 |
| 108 | Waddling gait (HP:0002515) | 1.65760404 |
| 109 | Fair hair (HP:0002286) | 1.65526140 |
| 110 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.63658732 |
| 111 | Intestinal atresia (HP:0011100) | 1.62507200 |
| 112 | Urethral obstruction (HP:0000796) | 1.61609657 |
| 113 | Type II lissencephaly (HP:0007260) | 1.60557806 |
| 114 | Progressive inability to walk (HP:0002505) | 1.60229693 |
| 115 | Metatarsus adductus (HP:0001840) | 1.59334404 |
| 116 | Birth length less than 3rd percentile (HP:0003561) | 1.58297817 |
| 117 | Atrioventricular block (HP:0001678) | 1.57326257 |
| 118 | Renal cortical cysts (HP:0000803) | 1.57059111 |
| 119 | Volvulus (HP:0002580) | 1.56496787 |
| 120 | Abnormal atrioventricular conduction (HP:0005150) | 1.55941028 |
| 121 | Preauricular pit (HP:0004467) | 1.55697034 |
| 122 | Periauricular skin pits (HP:0100277) | 1.55697034 |
| 123 | Congenital malformation of the right heart (HP:0011723) | 1.53218482 |
| 124 | Double outlet right ventricle (HP:0001719) | 1.53218482 |
| 125 | Hamartoma of the eye (HP:0010568) | 1.52777049 |
| 126 | Abnormality of the fovea (HP:0000493) | 1.51710019 |
| 127 | Fatigable weakness (HP:0003473) | 1.51658832 |
| 128 | Abnormality of the neuromuscular junction (HP:0003398) | 1.51658832 |
| 129 | Short palpebral fissure (HP:0012745) | 1.51396939 |
| 130 | Metaphyseal dysplasia (HP:0100255) | 1.51376354 |
| 131 | Tongue fasciculations (HP:0001308) | 1.51061876 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.50931829 |
| 133 | Ependymoma (HP:0002888) | 1.50004239 |
| 134 | Long clavicles (HP:0000890) | 1.49364886 |
| 135 | Agnosia (HP:0010524) | 1.49237387 |
| 136 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.49194154 |
| 137 | Albinism (HP:0001022) | 1.48305087 |
| 138 | Hypokinesia (HP:0002375) | 1.48083958 |
| 139 | Progressive muscle weakness (HP:0003323) | 1.45553969 |
| 140 | Hyperphosphatemia (HP:0002905) | 1.45091926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 5.72772046 |
| 2 | FRK | 4.23012147 |
| 3 | TTN | 4.18946574 |
| 4 | NEK1 | 3.31840328 |
| 5 | PHKG2 | 3.08995837 |
| 6 | PHKG1 | 3.08995837 |
| 7 | PDK2 | 2.72096776 |
| 8 | MST4 | 2.57949762 |
| 9 | STK24 | 2.57276408 |
| 10 | CDC7 | 2.46686539 |
| 11 | LATS1 | 2.37369577 |
| 12 | STK38L | 2.32129620 |
| 13 | EIF2AK3 | 2.31248528 |
| 14 | NEK9 | 2.27595582 |
| 15 | PDK4 | 2.13217146 |
| 16 | PDK3 | 2.13217146 |
| 17 | ZAK | 2.09439986 |
| 18 | ACVR1B | 1.85604577 |
| 19 | TRIM28 | 1.84911355 |
| 20 | PKN2 | 1.75202030 |
| 21 | CDK12 | 1.71289754 |
| 22 | MAP2K3 | 1.70952563 |
| 23 | LATS2 | 1.54140451 |
| 24 | PLK4 | 1.53783496 |
| 25 | DMPK | 1.47113598 |
| 26 | CDK8 | 1.41553692 |
| 27 | PNCK | 1.40558256 |
| 28 | MUSK | 1.38944317 |
| 29 | NME1 | 1.38169878 |
| 30 | MAP3K4 | 1.37820373 |
| 31 | STK3 | 1.34506432 |
| 32 | NEK2 | 1.32458725 |
| 33 | MAPK12 | 1.19772511 |
| 34 | TTK | 1.17702775 |
| 35 | MAP3K6 | 1.17387859 |
| 36 | RPS6KA4 | 1.14278801 |
| 37 | ERBB3 | 1.10497449 |
| 38 | TRIB3 | 1.09745356 |
| 39 | SRPK1 | 1.08990011 |
| 40 | PINK1 | 1.06401935 |
| 41 | CHEK2 | 1.06323592 |
| 42 | LIMK1 | 1.05027775 |
| 43 | MAP4K1 | 1.04325619 |
| 44 | MAP3K5 | 1.03736823 |
| 45 | PAK3 | 1.03264913 |
| 46 | TXK | 0.99439202 |
| 47 | DYRK3 | 0.98990086 |
| 48 | PIK3CA | 0.97350357 |
| 49 | MAP3K12 | 0.97255544 |
| 50 | BRSK2 | 0.95198925 |
| 51 | MELK | 0.95074265 |
| 52 | STK10 | 0.94790060 |
| 53 | EEF2K | 0.93206116 |
| 54 | MAP3K2 | 0.92778044 |
| 55 | BMPR1B | 0.92440377 |
| 56 | STK4 | 0.90793284 |
| 57 | MARK3 | 0.87760936 |
| 58 | CCNB1 | 0.87387334 |
| 59 | MAP3K7 | 0.86916654 |
| 60 | SGK2 | 0.85831361 |
| 61 | PRKAA1 | 0.84826072 |
| 62 | PLK1 | 0.84604756 |
| 63 | PLK2 | 0.84313754 |
| 64 | TGFBR1 | 0.84202841 |
| 65 | MAPK13 | 0.84155696 |
| 66 | CDK4 | 0.82968556 |
| 67 | CASK | 0.82763496 |
| 68 | MKNK1 | 0.81979170 |
| 69 | PRKAA2 | 0.81663640 |
| 70 | BMPR2 | 0.80531637 |
| 71 | FLT3 | 0.80119533 |
| 72 | TAOK2 | 0.79446913 |
| 73 | WEE1 | 0.79366689 |
| 74 | MAP3K3 | 0.78837092 |
| 75 | AURKB | 0.76985513 |
| 76 | PIK3CG | 0.76223138 |
| 77 | WNK3 | 0.75353084 |
| 78 | FER | 0.75331619 |
| 79 | FGFR2 | 0.74970126 |
| 80 | CSNK1G1 | 0.73155672 |
| 81 | TRPM7 | 0.73107803 |
| 82 | MKNK2 | 0.73026585 |
| 83 | EPHA3 | 0.70316054 |
| 84 | SGK3 | 0.68820161 |
| 85 | AKT3 | 0.68560791 |
| 86 | CAMKK2 | 0.67449751 |
| 87 | CHEK1 | 0.67272565 |
| 88 | SIK3 | 0.66515844 |
| 89 | PLK3 | 0.66220417 |
| 90 | ATR | 0.63356004 |
| 91 | EIF2AK1 | 0.62740431 |
| 92 | PTK2B | 0.59263272 |
| 93 | CAMK2D | 0.57932671 |
| 94 | BCR | 0.57694910 |
| 95 | ATM | 0.55325743 |
| 96 | LMTK2 | 0.54892982 |
| 97 | PRKCE | 0.53974563 |
| 98 | PIM1 | 0.53744513 |
| 99 | CDK9 | 0.53687746 |
| 100 | SCYL2 | 0.51720099 |
| 101 | ILK | 0.50868787 |
| 102 | MYLK | 0.50648007 |
| 103 | GRK1 | 0.50476167 |
| 104 | YES1 | 0.50139422 |
| 105 | TAOK1 | 0.49470735 |
| 106 | MAP3K8 | 0.47764807 |
| 107 | JAK1 | 0.46417239 |
| 108 | CSNK1G3 | 0.44377172 |
| 109 | BRD4 | 0.44165303 |
| 110 | EIF2AK2 | 0.43982412 |
| 111 | KIT | 0.43769493 |
| 112 | CAMK2G | 0.43756466 |
| 113 | MAP2K1 | 0.43630188 |
| 114 | STK38 | 0.43446171 |
| 115 | MAPKAPK3 | 0.42955230 |
| 116 | CAMK2A | 0.42694332 |
| 117 | MAPK7 | 0.41725028 |
| 118 | KSR1 | 0.41623994 |
| 119 | CSNK1G2 | 0.41465443 |
| 120 | CDK2 | 0.41154277 |
| 121 | MAP2K6 | 0.40475691 |
| 122 | CDK7 | 0.39765812 |
| 123 | BUB1 | 0.38804412 |
| 124 | TYK2 | 0.37218352 |
| 125 | PRKG1 | 0.35939437 |
| 126 | FGFR3 | 0.34857557 |
| 127 | PRKACB | 0.34777474 |
| 128 | MAPK11 | 0.34554335 |
| 129 | CSNK1D | 0.34272114 |
| 130 | CAMK4 | 0.33829383 |
| 131 | CSF1R | 0.33640945 |
| 132 | STK39 | 0.32110666 |
| 133 | ADRBK2 | 0.32100720 |
| 134 | ROCK1 | 0.31577387 |
| 135 | AKT2 | 0.31394280 |
| 136 | BRSK1 | 0.31058374 |
| 137 | MAP3K14 | 0.30921777 |
| 138 | CDK1 | 0.30165452 |
| 139 | RPS6KB2 | 0.28979986 |
| 140 | CHUK | 0.28755334 |
| 141 | MAP2K7 | 0.28446077 |
| 142 | NLK | 0.28071302 |
| 143 | JAK3 | 0.27524720 |
| 144 | MAP2K4 | 0.26822044 |
| 145 | MTOR | 0.26692761 |
| 146 | ERBB4 | 0.26492198 |
| 147 | BRAF | 0.26453357 |
| 148 | KSR2 | 0.24854819 |
| 149 | RPS6KB1 | 0.23653940 |
| 150 | MARK1 | 0.21689293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.45874259 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.92621632 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.90708682 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.66009864 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.54372466 |
| 6 | Cell cycle_Homo sapiens_hsa04110 | 2.45308219 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.37882470 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.37411051 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.29993211 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.24034122 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.14662860 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.08097528 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.06924520 |
| 14 | RNA degradation_Homo sapiens_hsa03018 | 2.05373389 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.99311877 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97562402 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.97131718 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.94005041 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.86329892 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.74116542 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.70300245 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67752024 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.66310092 |
| 24 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.64363479 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.61776804 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.59834534 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.57995877 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.57246647 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53109463 |
| 30 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52438944 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45195001 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44788288 |
| 33 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.34855422 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.33596237 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31204986 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.30295118 |
| 37 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.25749895 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24370003 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.20510147 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20072866 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19064095 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.17860392 |
| 43 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13450583 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.12443171 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12031227 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.11935202 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.11279917 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10517501 |
| 49 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.08785492 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.06039368 |
| 51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.05217686 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04890508 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.03720640 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02540894 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00121127 |
| 56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99895882 |
| 57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98788952 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95516265 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92349463 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91827560 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91407454 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89598524 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89405848 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.88730992 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86218125 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85585394 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.83528440 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83260559 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81994883 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81957760 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81931866 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81104170 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81081304 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80540041 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80188802 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.79349739 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78076107 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76168160 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76097760 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75921923 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74772950 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.74464394 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74422094 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74170031 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73078385 |
| 86 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71993083 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.71977076 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71597534 |
| 89 | Purine metabolism_Homo sapiens_hsa00230 | 0.71228019 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70932437 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.70823355 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69391650 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69043316 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68351375 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68235730 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65856831 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63587559 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.62908214 |
| 99 | Proteasome_Homo sapiens_hsa03050 | 0.62687214 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62291728 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.62042082 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62025526 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61524792 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61318565 |
| 105 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61176946 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.60088648 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59605955 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.59445233 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58803826 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58155866 |
| 111 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58112362 |
| 112 | Phototransduction_Homo sapiens_hsa04744 | 0.57165292 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57095095 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.54861064 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53684042 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.53321564 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.53165737 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52445845 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51762104 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51640271 |
| 121 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51382607 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.51167724 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.50586299 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50107267 |
| 125 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49964442 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49626239 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.49603803 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49573836 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48224881 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48110265 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48006292 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48005780 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47850130 |
| 134 | Melanoma_Homo sapiens_hsa05218 | 0.47111157 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46929119 |
| 136 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46719068 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45670592 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45008029 |
| 139 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44989647 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.44033041 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43767879 |
| 142 | Glioma_Homo sapiens_hsa05214 | 0.42710446 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.33979327 |
| 144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33883204 |
| 145 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33729259 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33432307 |
| 147 | Shigellosis_Homo sapiens_hsa05131 | 0.29817113 |
| 148 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29272198 |
| 149 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28043892 |
| 150 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25805110 |
| 151 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.25102926 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23319882 |

